Article Text

Download PDFPDF
Is Lymphadenectomy Justified in Endometrial Cancer?
  1. Johannes Dietl, MD, PhD
  1. Department of Obstetrics and Gynecology, University of Wuerzburg, Wuerzburg, Germany.
  1. Address correspondence and reprint requests to Johannes Dietl, MD, PhD, Department of Obstetrics and Gynecology, University of Wuerzburg, Josef-Schneider-Straße 2, D-97080 Wuerzburg, Germany. E-mail: dietl_j{at}


Endometrial cancer has in the meantime become the most frequent malignant tumor of the female genital tract. With a 5-year survival rate of 82% for all stages and more than 90% for the most common stage I, it is a carcinoma with an excellent prognosis. Against this background and in light of the results of recent studies, the value of extensive surgical staging including pelvic and para-aortic lymphadenectomy beyond the standard therapy of hysterectomy with bilateral adnexectomy must be questioned.

  • Endometrial cancer
  • Lymphadenectomy
  • Randomized trials

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.